List of Tables
Table 1. Global Oral Thrombopoietin Receptor Agonists Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Oral Thrombopoietin Receptor Agonists Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Oral Thrombopoietin Receptor Agonists Market Competitive Situation by Manufacturers in 2025
Table 4. Global Oral Thrombopoietin Receptor Agonists Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Oral Thrombopoietin Receptor Agonists Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Oral Thrombopoietin Receptor Agonists Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Oral Thrombopoietin Receptor Agonists Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Oral Thrombopoietin Receptor Agonists Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Oral Thrombopoietin Receptor Agonists, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Oral Thrombopoietin Receptor Agonists, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Oral Thrombopoietin Receptor Agonists, Product Types and Applications
Table 12. Global Key Manufacturers of Oral Thrombopoietin Receptor Agonists, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Thrombopoietin Receptor Agonists Companies by Tier (Tier 1, Tier 2, Tier 3), based on Oral Thrombopoietin Receptor Agonists Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Thrombopoietin Receptor Agonists Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Oral Thrombopoietin Receptor Agonists Sales by Region (K Units), 2021–2026
Table 18. Global Oral Thrombopoietin Receptor Agonists Sales Market Share by Region (2021–2026)
Table 19. Global Oral Thrombopoietin Receptor Agonists Sales by Region (K Units), 2027–2032
Table 20. Global Oral Thrombopoietin Receptor Agonists Sales Market Share by Region (2027–2032)
Table 21. Global Oral Thrombopoietin Receptor Agonists Revenue by Region (US$ Million), 2021–2026
Table 22. Global Oral Thrombopoietin Receptor Agonists Revenue Market Share by Region (2021–2026)
Table 23. Global Oral Thrombopoietin Receptor Agonists Revenue by Region (US$ Million), 2027–2032
Table 24. Global Oral Thrombopoietin Receptor Agonists Revenue Market Share by Region (2027–2032)
Table 25. North America Oral Thrombopoietin Receptor Agonists Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Oral Thrombopoietin Receptor Agonists Sales by Country (K Units), 2021–2026
Table 27. North America Oral Thrombopoietin Receptor Agonists Sales by Country (K Units), 2027–2032
Table 28. North America Oral Thrombopoietin Receptor Agonists Revenue by Country (US$ Million), 2021–2026
Table 29. North America Oral Thrombopoietin Receptor Agonists Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Oral Thrombopoietin Receptor Agonists Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Oral Thrombopoietin Receptor Agonists Sales by Country (K Units), 2021–2026
Table 32. Europe Oral Thrombopoietin Receptor Agonists Sales by Country (K Units), 2027–2032
Table 33. Europe Oral Thrombopoietin Receptor Agonists Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Oral Thrombopoietin Receptor Agonists Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Oral Thrombopoietin Receptor Agonists Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Oral Thrombopoietin Receptor Agonists Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Oral Thrombopoietin Receptor Agonists Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Oral Thrombopoietin Receptor Agonists Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Oral Thrombopoietin Receptor Agonists Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Oral Thrombopoietin Receptor Agonists Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Oral Thrombopoietin Receptor Agonists Sales by Country (K Units), 2021–2026
Table 42. Latin America Oral Thrombopoietin Receptor Agonists Sales by Country (K Units), 2027–2032
Table 43. Latin America Oral Thrombopoietin Receptor Agonists Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Oral Thrombopoietin Receptor Agonists Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Oral Thrombopoietin Receptor Agonists Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Oral Thrombopoietin Receptor Agonists Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Oral Thrombopoietin Receptor Agonists Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Oral Thrombopoietin Receptor Agonists Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Oral Thrombopoietin Receptor Agonists Revenue by Country (US$ Million), 2027–2032
Table 50. Global Oral Thrombopoietin Receptor Agonists Sales (K Units) by Type (2021–2026)
Table 51. Global Oral Thrombopoietin Receptor Agonists Sales (K Units) by Type (2027–2032)
Table 52. Global Oral Thrombopoietin Receptor Agonists Sales Market Share by Type (2021–2026)
Table 53. Global Oral Thrombopoietin Receptor Agonists Sales Market Share by Type (2027–2032)
Table 54. Global Oral Thrombopoietin Receptor Agonists Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Oral Thrombopoietin Receptor Agonists Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Oral Thrombopoietin Receptor Agonists Revenue Market Share by Type (2021–2026)
Table 57. Global Oral Thrombopoietin Receptor Agonists Revenue Market Share by Type (2027–2032)
Table 58. Global Oral Thrombopoietin Receptor Agonists Price (US$/Unit) by Type (2021–2026)
Table 59. Global Oral Thrombopoietin Receptor Agonists Price (US$/Unit) by Type (2027–2032)
Table 60. Global Oral Thrombopoietin Receptor Agonists Sales (K Units) by Application (2021–2026)
Table 61. Global Oral Thrombopoietin Receptor Agonists Sales (K Units) by Application (2027–2032)
Table 62. Global Oral Thrombopoietin Receptor Agonists Sales Market Share by Application (2021–2026)
Table 63. Global Oral Thrombopoietin Receptor Agonists Sales Market Share by Application (2027–2032)
Table 64. Global Oral Thrombopoietin Receptor Agonists Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Oral Thrombopoietin Receptor Agonists Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Oral Thrombopoietin Receptor Agonists Revenue Market Share by Application (2021–2026)
Table 67. Global Oral Thrombopoietin Receptor Agonists Revenue Market Share by Application (2027–2032)
Table 68. Global Oral Thrombopoietin Receptor Agonists Price (US$/Unit) by Application (2021–2026)
Table 69. Global Oral Thrombopoietin Receptor Agonists Price (US$/Unit) by Application (2027–2032)
Table 70. Shionogi Company Information
Table 71. Shionogi Description and Business Overview
Table 72. Shionogi Oral Thrombopoietin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Shionogi Oral Thrombopoietin Receptor Agonists Product
Table 74. Shionogi Recent Developments/Updates
Table 75. Novartis Company Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Oral Thrombopoietin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Novartis Oral Thrombopoietin Receptor Agonists Product
Table 79. Novartis Recent Developments/Updates
Table 80. AkaRx Company Information
Table 81. AkaRx Description and Business Overview
Table 82. AkaRx Oral Thrombopoietin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. AkaRx Oral Thrombopoietin Receptor Agonists Product
Table 84. AkaRx Recent Developments/Updates
Table 85. Jiangsu Hengrui Pharmaceuticals Company Information
Table 86. Jiangsu Hengrui Pharmaceuticals Description and Business Overview
Table 87. Jiangsu Hengrui Pharmaceuticals Oral Thrombopoietin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Jiangsu Hengrui Pharmaceuticals Oral Thrombopoietin Receptor Agonists Product
Table 89. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 90. 3SBio Company Information
Table 91. 3SBio Description and Business Overview
Table 92. 3SBio Oral Thrombopoietin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. 3SBio Oral Thrombopoietin Receptor Agonists Product
Table 94. 3SBio Recent Developments/Updates
Table 95. Sichuan Kelun Pharmaceutical Company Information
Table 96. Sichuan Kelun Pharmaceutical Description and Business Overview
Table 97. Sichuan Kelun Pharmaceutical Oral Thrombopoietin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Sichuan Kelun Pharmaceutical Oral Thrombopoietin Receptor Agonists Product
Table 99. Sichuan Kelun Pharmaceutical Recent Developments/Updates
Table 100. Qilu Pharmaceutical Company Information
Table 101. Qilu Pharmaceutical Description and Business Overview
Table 102. Qilu Pharmaceutical Oral Thrombopoietin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Qilu Pharmaceutical Oral Thrombopoietin Receptor Agonists Product
Table 104. Qilu Pharmaceutical Recent Developments/Updates
Table 105. Grand Pharmaceutical Company Information
Table 106. Grand Pharmaceutical Description and Business Overview
Table 107. Grand Pharmaceutical Oral Thrombopoietin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Grand Pharmaceutical Oral Thrombopoietin Receptor Agonists Product
Table 109. Grand Pharmaceutical Recent Developments/Updates
Table 110. Chia Tai Tianqing Pharmaceutical Company Information
Table 111. Chia Tai Tianqing Pharmaceutical Description and Business Overview
Table 112. Chia Tai Tianqing Pharmaceutical Oral Thrombopoietin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Chia Tai Tianqing Pharmaceutical Oral Thrombopoietin Receptor Agonists Product
Table 114. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 115. Shanghai Fosun Pharmaceutical Company Information
Table 116. Shanghai Fosun Pharmaceutical Description and Business Overview
Table 117. Shanghai Fosun Pharmaceutical Oral Thrombopoietin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Shanghai Fosun Pharmaceutical Oral Thrombopoietin Receptor Agonists Product
Table 119. Shanghai Fosun Pharmaceutical Recent Developments/Updates
Table 120. Teva Company Information
Table 121. Teva Description and Business Overview
Table 122. Teva Oral Thrombopoietin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Teva Oral Thrombopoietin Receptor Agonists Product
Table 124. Teva Recent Developments/Updates
Table 125. Annora Pharma Company Information
Table 126. Annora Pharma Description and Business Overview
Table 127. Annora Pharma Oral Thrombopoietin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Annora Pharma Oral Thrombopoietin Receptor Agonists Product
Table 129. Annora Pharma Recent Developments/Updates
Table 130. Hetero Company Information
Table 131. Hetero Description and Business Overview
Table 132. Hetero Oral Thrombopoietin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Hetero Oral Thrombopoietin Receptor Agonists Product
Table 134. Hetero Recent Developments/Updates
Table 135. Actavis Laboratories Company Information
Table 136. Actavis Laboratories Description and Business Overview
Table 137. Actavis Laboratories Oral Thrombopoietin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Actavis Laboratories Oral Thrombopoietin Receptor Agonists Product
Table 139. Actavis Laboratories Recent Developments/Updates
Table 140. Amneal Pharmaceuticals Company Information
Table 141. Amneal Pharmaceuticals Description and Business Overview
Table 142. Amneal Pharmaceuticals Oral Thrombopoietin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Amneal Pharmaceuticals Oral Thrombopoietin Receptor Agonists Product
Table 144. Amneal Pharmaceuticals Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Oral Thrombopoietin Receptor Agonists Distributors List
Table 148. Oral Thrombopoietin Receptor Agonists Customers List
Table 149. Oral Thrombopoietin Receptor Agonists Market Trends
Table 150. Oral Thrombopoietin Receptor Agonists Market Drivers
Table 151. Oral Thrombopoietin Receptor Agonists Market Challenges
Table 152. Oral Thrombopoietin Receptor Agonists Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Oral Thrombopoietin Receptor Agonists
Figure 2. Global Oral Thrombopoietin Receptor Agonists Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Oral Thrombopoietin Receptor Agonists Market Share by Type: 2025 & 2032
Figure 4. Herombopag Product Picture
Figure 5. Lusutrombopag Product Picture
Figure 6. Avatrombopag Product Picture
Figure 7. Eltrombopag Product Picture
Figure 8. Global Oral Thrombopoietin Receptor Agonists Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Oral Thrombopoietin Receptor Agonists Market Share by Application: 2025 & 2032
Figure 10. Hospital and Clinic
Figure 11. Pharmacy
Figure 12. Other
Figure 13. Global Oral Thrombopoietin Receptor Agonists Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Oral Thrombopoietin Receptor Agonists Market Size (US$ Million), 2021–2032
Figure 15. Global Oral Thrombopoietin Receptor Agonists Sales (K Units), 2021–2032
Figure 16. Global Oral Thrombopoietin Receptor Agonists Average Price (US$/Unit), 2021–2032
Figure 17. Oral Thrombopoietin Receptor Agonists Report Years Considered
Figure 18. Oral Thrombopoietin Receptor Agonists Sales Share by Manufacturers in 2025
Figure 19. Global Oral Thrombopoietin Receptor Agonists Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Oral Thrombopoietin Receptor Agonists Players: Market Share by Revenue in Oral Thrombopoietin Receptor Agonists in 2025
Figure 21. Oral Thrombopoietin Receptor Agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Oral Thrombopoietin Receptor Agonists Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Oral Thrombopoietin Receptor Agonists Sales Market Share by Country (2021–2032)
Figure 24. North America Oral Thrombopoietin Receptor Agonists Revenue Market Share by Country (2021–2032)
Figure 25. United States Oral Thrombopoietin Receptor Agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Oral Thrombopoietin Receptor Agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Oral Thrombopoietin Receptor Agonists Sales Market Share by Country (2021–2032)
Figure 28. Europe Oral Thrombopoietin Receptor Agonists Revenue Market Share by Country (2021–2032)
Figure 29. Germany Oral Thrombopoietin Receptor Agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Oral Thrombopoietin Receptor Agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Oral Thrombopoietin Receptor Agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Oral Thrombopoietin Receptor Agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Oral Thrombopoietin Receptor Agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Oral Thrombopoietin Receptor Agonists Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Oral Thrombopoietin Receptor Agonists Revenue Market Share by Region (2021–2032)
Figure 36. China Oral Thrombopoietin Receptor Agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Oral Thrombopoietin Receptor Agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Oral Thrombopoietin Receptor Agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Oral Thrombopoietin Receptor Agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Oral Thrombopoietin Receptor Agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Oral Thrombopoietin Receptor Agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Oral Thrombopoietin Receptor Agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Oral Thrombopoietin Receptor Agonists Sales Market Share by Country (2021–2032)
Figure 44. Latin America Oral Thrombopoietin Receptor Agonists Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Oral Thrombopoietin Receptor Agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Oral Thrombopoietin Receptor Agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Oral Thrombopoietin Receptor Agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Oral Thrombopoietin Receptor Agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Oral Thrombopoietin Receptor Agonists Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Oral Thrombopoietin Receptor Agonists Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Oral Thrombopoietin Receptor Agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Oral Thrombopoietin Receptor Agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Oral Thrombopoietin Receptor Agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Oral Thrombopoietin Receptor Agonists by Type (2021–2032)
Figure 55. Global Revenue Market Share of Oral Thrombopoietin Receptor Agonists by Type (2021–2032)
Figure 56. Global Oral Thrombopoietin Receptor Agonists Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Oral Thrombopoietin Receptor Agonists by Application (2021–2032)
Figure 58. Global Revenue Market Share of Oral Thrombopoietin Receptor Agonists by Application (2021–2032)
Figure 59. Global Oral Thrombopoietin Receptor Agonists Price (US$/Unit) by Application (2021–2032)
Figure 60. Oral Thrombopoietin Receptor Agonists Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
